NDATOPICALCREAM
Approved
Dec 2001
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
3/8 — Basic
Drug data last refreshed 17h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Lotrimin Ultra is a topical antifungal cream containing butenafine hydrochloride, approved for treating fungal skin infections such as athlete's foot, jock itch, and ringworm. It works by disrupting fungal cell membrane integrity through inhibition of sterol synthesis. The product is a benzylamine antifungal for direct application to affected skin areas.
LOE Approaching
As a mature OTC/topical product approaching loss of exclusivity, the brand team likely operates in maintenance mode with focus on retail distribution and consumer awareness rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDIS
Started Jan 2019
42 enrolled
Tinea Pedis
Career Relevance
Lotrimin Ultra offers limited career growth due to its mature, OTC-focused market position and impending LOE; roles are predominantly commercial and sales-oriented rather than clinical or innovative. Career advancement on this product typically leads to either retail/consumer marketing specialization or transition to newer, higher-growth assets.
Brand Manager
Worked on LOTRIMIN ULTRA at Bayer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.